London, England, United Kingdom In 1978 was created Newton Investment Management, which is appeared as VC.
The usual things for fund are deals in the range of 50 - 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. The important activity for fund was in 2019.
Among the most successful fund investment fields, there are Therapeutics, Biotechnology. Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. Among the most popular portfolio startups of the fund, we may highlight Amphivena Therapeutics.
The typical case for the fund is to invest in rounds with more than 10 participants. The meaningful sponsors for the fund in investment in the same round are Tekla Capital Management, Qiming Venture Partners, NanoDimension.
Related Funds
| Fund Name | Location |
| Austin Technology Incubator | Austin, Texas, United States |
| BoostLAB | - |
| Daole Huiying Touzi | China, Jiangxi, Yingtan |
| GVT Fund | Taipei, Taiwan |
| Impulse International for Telecommunications | Al Asimah, Al Kuwayt, Kuwait |
| Jiangnan Renhe Xin Nengyuan | China, Jiangsu, Wuxi Shi |
| Kirin Holdings | Chiyoda, Japan |
| KTM Capital | Australia, New South Wales, Sydney |
| Milepost Ventures | California, San Francisco, United States |
| Nautilus Ventures | California, Cupertino, United States |
| Philos & Partners | - |
| Silicon Catalyst | California, Santa Clara, United States |
| SPA Capital Services | Delhi, India, New Delhi |
| Techpeaks | Italy, Trentino-Alto Adige, Trento |
| TIANMA | Anhui, China, Tianchang |
| Tokyo Electric Power | Japan, Tokyo |
| TPP Capital Advisors | Japan, Tokyo |
| Valley Ventures | Arizona, Phoenix, United States |
| ZIG Capital | New York, New York, United States |
Discover 5 more decision makers Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Aspen Neuroscience | $147M | 09 May 2022 | San Diego, California, United States | ||
Amphivena Therapeutics | $62M | 24 Sep 2019 | South San Francisco, California, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Aspen Neuroscience | $147M | 09 May 2022 | San Diego, California, United States | ||
Amphivena Therapeutics | $62M | 24 Sep 2019 | South San Francisco, California, United States |
